Information About the Hepatitis C Virus – Part 1 | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Information About the Hepatitis C Virus – Part 1

 
Part 1 | Part 2 | Part 3
 
Anti-Selectin
Therapy Against Hepatic
Ischemia-Reperfusion Injury

Bile
Formation: Do Not Ignore the Role of
Plasma Membrane

Clinical
Profile Liver Disease

Cost-Effectiveness
of Hepatitis A Vaccination

Increased
Lipopolysaccharide Binding Protein

Hepatocarcinogenesis:
Identification of HSP70

Mortality
in Patients With Hepatopulmonary Syndrome

Minimal
Hepatic Encephalopathy Impairs Fitness to Drive

Antibiotic Prophylaxis
After Endoscopic Therapy

Pretransplant
and Posttransplant Survival

Chronic
Liver Disease Mortality
in the United States, 1990-1998

Ursodeoxycholic
Acid for Treatment of
Nonalcoholic Steatohepatitis

Serum
Bacterial DNA in Patients
With Advanced Cirrhosis and Ascites

Tumor
Cells in Patients With Liver Cancer

Is
Fibrolamellar Carcinoma Different From
Hepatocellular Carcinoma?

Frequent
Compartmentalization of
Hepatitis C Virus Variants

The
Predictive Value of Fibrotest vs. APRI for the
Diagnosis of Fibrosis in Chronic Hepatitis C

LANDMARKS
IN HEPATOLOGY — Old Scratch

Unexpected
Host Range of Hepatitis C Virus Replicons

Management
of Adult Patients With
Ascites Due to Cirrhosis

Cancer-Associated
Molecular Signature
in the Tissue Samples of Patients With Cirrhosis

Risks of a Range
of Alcohol Intake
on Hepatitis C-Related Fibrosis

Detection
and Identifcation of Tumor-Associated
Protein Variants in Human Hepatocellular Carcinomas

A Common Staging
System for Hepatocellular Carcinoma

Vitamin
E Therapy in Patients With NASH

 
Part 1 | Part 2 | Part 3
 
Table
of Contents